Faculty of Health, Medicine and Behavioural Sciences
Research Fellow
School of Health and Rehabilitation Sciences
Faculty of Health, Medicine and Behavioural Sciences
Availability:
Available for supervision
Dr Jonathan Davies is a chronic pain researcher working to improve how pain is understood, assessed and treated. His research focuses on pain phenotyping, precision pain care, and the psychological, physiological and contextual factors that shape pain and treatment response.
At UQ’s Centre for Innovation in Pain and Health Research, he contributes to DISCERN, an NHMRC Synergy-funded multidisciplinary research program developing and validating new approaches to pain assessment. A major focus of his work is DECIPHER PAIN, a standardised, multimodal tool designed to characterise the relative contributions of nociceptive, neuropathic and nociplastic pain and support more personalised care.
His research integrates clinical assessment, quantitative sensory testing, experimental pain methods, psychophysiology, digital health and population data. He is particularly interested in how physiological signals, behaviour, language, psychosocial context and real-world health data can be combined to better understand individual differences in pain and treatment outcomes.
His broader expertise includes placebo and nocebo effects, mindfulness, mental health, quality of life, health outcome measurement and population health. His work aims to support more precise, scalable and patient-centred approaches to pain research and care.
Australian Institute for Bioengineering and Nanotechnology
Availability:
Available for supervision
Dr Aleksandr Kakinen is an NHMRC Emerging Leadership Fellow (EL1) at AIBN, UQ. His research investigates how protein aggregation, inflammation, and infection contribute to neurodegenerative diseases, particularly Alzheimer’s and Parkinson’s disease.
His work focuses on amyloid proteins — misfolded proteins that assemble into toxic aggregates in the brain — and how these assemblies interact with inflammatory and microbial factors to influence disease progression. He combines approaches from biophysics, structural biology, molecular neuroscience, neuroinflammation, and nanomedicine to understand disease mechanisms and identify new therapeutic opportunities.
Dr Kakinen’s research program includes:
amyloid aggregation and cross-seeding mechanisms
infection- and inflammation-driven neurodegeneration
structural and biological diversity of amyloid assemblies
neuroinflammatory responses in neuronal and microglial models
brain-targeted delivery of neuroprotective molecules and peptides
He has authored over 65 peer-reviewed publications in leading journals, including Nature Communications, Advanced Science, ACS Nano, and Chemical Reviews. His current work aims to link fundamental mechanisms of protein aggregation with translational strategies for diagnosis, prevention, and treatment of neurodegenerative diseases.
